Glucagon-like peptide 1 (GLP-1).

• Müller TD Institute for Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany; German Center for Diabetes Research (DZD), Neuherberg, Germany; Department of Pharmacology and Experimental Therapy, Institute of Experimental and Clinical Pharmacology and Toxicology, Eberhard Karls University Hospitals and Clinics, Tübingen, Germany. Electronic address: timo.mueller@helmholtz-muenchen.de.
• Finan B Novo Nordisk Research Center Indianapolis, Indianapolis, IN, USA.
• Bloom SR Division of Diabetes, Endocrinology and Metabolism, Imperial College London, London, UK.
• D'Alessio D Division of Endocrinology, Duke University Medical Center, Durham, NC, USA.
• Drucker DJ The Department of Medicine, Lunenfeld-Tanenbaum Research Institute, Mt. Sinai Hospital, University of Toronto, Ontario, M5G1X5, Canada.
• Flatt PR SAAD Centre for Pharmacy & Diabetes, Ulster University, Coleraine, Northern Ireland, UK.
• Fritsche A German Center for Diabetes Research (DZD), Neuherberg, Germany; Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany; Division of Endocrinology, Diabetology, Vascular Disease, Nephrology and Clinical Chemistry, Department of Internal Medicine, University of Tübingen, Tübingen, Germany.
• Gribble F Metabolic Research Laboratories and Medical Research Council Metabolic Diseases Unit, Wellcome Trust-Medical Research Council, Institute of Metabolic Science, Addenbrooke's Hospital, University of Cambridge, Cambridge, CB2 0QQ, UK.
• Grill HJ Institute of Diabetes, Obesity and Metabolism, Department of Psychology, University of Pennsylvania, Philadelphia, PA, 19104, USA.
• Habener JF Laboratory of Molecular Endocrinology, Massachusetts General Hospital, Harvard University, Boston, MA, USA.
• Holst JJ Novo Nordisk Foundation Center for Basic Metabolic Research, Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
• Langhans W Physiology and Behavior Laboratory, ETH Zurich, Schwerzenbach, Switzerland.
• Meier JJ Diabetes Division, St Josef Hospital, Ruhr-University Bochum, Bochum, Germany.
• Nauck MA Diabetes Center Bochum-Hattingen, St Josef Hospital (Ruhr-Universität Bochum), Bochum, Germany.
• Perez-Tilve D Department of Internal Medicine, University of Cincinnati-College of Medicine, Cincinnati, OH, USA.
• Pocai A Cardiovascular & ImmunoMetabolism, Janssen Research & Development, Welsh and McKean Roads, Spring House, PA, 19477, USA.
• Reimann F Metabolic Research Laboratories and Medical Research Council Metabolic Diseases Unit, Wellcome Trust-Medical Research Council, Institute of Metabolic Science, Addenbrooke's Hospital, University of Cambridge, Cambridge, CB2 0QQ, UK.
• Sandoval DA Department of Surgery, University of Michigan Medical School, Ann Arbor, MI, USA.
• Schwartz TW Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, DL-2200, Copenhagen, Denmark; Department of Biomedical Sciences, University of Copenhagen, DK-2200, Copenhagen, Denmark.
• Seeley RJ Department of Surgery, University of Michigan Medical School, Ann Arbor, MI, USA.
• Stemmer K Institute for Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany; German Center for Diabetes Research (DZD), Neuherberg, Germany.
• Tang-Christensen M Obesity Research, Global Drug Discovery, Novo Nordisk A/S, Måløv, Denmark.
• Woods SC Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati, Cincinnati, OH, USA.
• DiMarchi RD Novo Nordisk Research Center Indianapolis, Indianapolis, IN, USA; Department of Chemistry, Indiana University, Bloomington, IN, USA.
• Tschöp MH German Center for Diabetes Research (DZD), Neuherberg, Germany; Division of Metabolic Diseases, Department of Medicine, Technische Universität München, Munich, Germany; Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany.

Show more…

Diabetes

GLP-1

Glucagon

Incretin

Insulin

Obesity

Blood Glucose

Diabetes Mellitus, Type 2

Gastric Inhibitory Polypeptide

Glucagon-Like Peptide 1

Glucagon-Like Peptide-1 Receptor

Glucose

Humans

Hypoglycemic Agents

Insulin

Insulin Secretion

Insulin-Secreting Cells

Obesity

Receptors, Glucagon